HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Esther Schnettler Selected Research

Ribonuclease III (RNase III)

1/2022Mutational analysis of Aedes aegypti Dicer 2 provides insights into the biogenesis of antiviral exogenous small interfering RNAs.
1/2021An Aedes aegypti-Derived Ago2 Knockout Cell Line to Investigate Arbovirus Infections.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Esther Schnettler Research Topics

Disease

15Infections
01/2022 - 01/2012
3Virus Diseases (Viral Diseases)
11/2020 - 03/2012
3Arbovirus Infections
01/2017 - 03/2013
2Bunyaviridae Infections
01/2017 - 02/2016
1Medulloblastoma
01/2019
1Persistent Infection
11/2016
1Inflammation (Inflammations)
01/2016
1Bites and Stings (Sting)
01/2016

Drug/Important Bio-Agent (IBA)

9Antiviral Agents (Antivirals)IBA
01/2022 - 07/2013
6RNA (Ribonucleic Acid)IBA
12/2018 - 03/2012
5Small Interfering RNA (siRNA)IBA
11/2020 - 07/2013
4Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2013
4Piwi-Interacting RNAIBA
12/2018 - 07/2013
2Ribonuclease III (RNase III)IBA
01/2022 - 01/2021
2InterferonsIBA
08/2017 - 04/2015
2MicroRNAs (MicroRNA)IBA
07/2017 - 03/2012
1Amino AcidsFDA Link
01/2022
1RNA Precursors (Precursor, mRNA)IBA
01/2019
1RNA Polymerase I (Polymerase I, RNA)IBA
01/2019
15S Ribosomal RNAIBA
01/2019
1Biological Control AgentsIBA
12/2018
1Complementary DNA (cDNA)IBA
10/2018
1CytokinesIBA
08/2017
1VaccinesIBA
02/2016
1Potassium Channels (Potassium Channel)IBA
02/2016
1InflammasomesIBA
01/2016
1NucleotidesIBA
03/2013
1DNA (Deoxyribonucleic Acid)IBA
03/2012
1Messenger RNA (mRNA)IBA
03/2012
1Monophenol Monooxygenase (Tyrosinase)IBA
01/2012

Therapy/Procedure

1Therapeutics
02/2016